Search
Edwards Lifesciences Corp
EWAdd to Watchlist
89.900USD
+0.120+0.13%
Close 09-04 16:00（ET）
51.84BMarket Cap
47.74P/E TTM
Forecast
Currency: USD Updated: 2026-09-04The current earnings forecast score of Edwards Lifesciences Corp is 8.06, ranking 65 out of 202 in the Healthcare Equipment & Supplies industry. The average price target is 95.50, with a high of 105.00 and a low of 72.00.
Analyst Rating
Based on
32
analysts
Buy
Current Rating
99.843
Target Price
+11.21%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Edwards Lifesciences Corp
EW
32
Intuitive Surgical Inc
ISRG
34
Boston Scientific Corp
BSX
34
Thermo Fisher Scientific Inc
TMO
32
Veeva Systems Inc
VEEV
30
Danaher Corp
DHR
28
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Edwards Lifesciences Corp's expected revenue for the next quarter?
Edwards Lifesciences Corp's expected revenue is 1.68B.
What is Edwards Lifesciences Corp's price target?
Analysts forecast that Edwards Lifesciences Corp's price target is USD 95.50, with the highest forecast at USD 105.00 and the lowest forecast at USD 72.00.
How have Edwards Lifesciences CorpEW's recent earnings per share performed?
The market expectation was USD 0.42, while Edwards Lifesciences CorpEW's earnings per share (EPS) for the previous quarter was USD 0.66. EPS for the next quarter is expected at USD 0.74.
What is the analyst rating for Edwards Lifesciences Corp?
Based on the ratings of Edwards Lifesciences Corp's stock from 32 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.